MDS | Tumor

There’s Always Hope After an ‘Incurable’ Cancer Diagnosis, Thanks to Devoted Researchers

November 18th 2021, 6:00pm

A cancer survivor explains how the new treatments coming out for all types of cancer give her hope. “If we are diagnosed today, a cure or remission may come out next week or next month, or next year to give us additional time to live,” she writes.

Phase 2 Trial Initiated for Second Line Treatment of AML and MDS

November 18th 2021, 12:00am

A phase 2 trial of aspacytarabine (BST-236) was initiated in patients with AML and MDS.

Cancer Survivors Are All on a Journey

September 30th 2021, 5:00pm

A cancer survivor explains why each person experiences cancer differently – from side effects to treatments and more.

In the Mist of My Fear: Experiences With MDS

August 10th 2021, 1:30pm

A patient with MDS writes about facing fears during the treatment journey.

The Basics of MDS: Diagnosis and Staging

August 4th 2021, 9:00pm

How are myelodysplastic syndromes diagnosed and staged? What causes them? An expert from Moffit Cancer Center offers insight.

FDA Grants Venclexta/Onureg a Breakthrough Therapy Designation for Untreated MDS

July 22nd 2021, 12:00am

The FDA will expedite the development and review of the drug combination to treat untreated intermediate- high- and very high-risk myelodysplastic syndrome.

Vidaza With Novel Drug Shows Improvement for Myelodysplastic Syndromes With Genetic Mutations and Acute Myeloid Leukemia

April 2nd 2021, 9:00pm

Previously, Vidaza alone showed poor response rates for patients with TP53-mutated, myelodysplastic syndromes and acute myeloid leukemia, but adding the novel agent eprenetapopt improved response rates and overall survival in this patient population.

A Multidisciplinary Team in Treating Myelodysplastic Syndromes

December 17th 2020, 5:00am

Possible Treatment Options for Myelodysplastic Syndromes

December 17th 2020, 5:00am

Luspatercept in the Treatment of Myelodysplastic Syndromes

December 17th 2020, 5:00am